FDA.reportPublic FDA data

NDC 50090-5339-01 - meloxicam

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
50090-5339
Requested NDC
50090-5339-01
Package NDCs from labels
50090-5339-0, 50090-5339-3, 50090-5339-7, 50090-5339-1, 50090-5339-4, 50090-5339-6, 50090-5339-2, 50090-5339-01
Manufacturer
A-S Medication Solutions
Effective date
2024-12-12
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
meloxicam - A-S Medication SolutionsA-S Medication Solutions2024-12-12HUMAN PRESCRIPTION DRUG LABEL

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDCEffectiveRelated label
50090-5339-02023-02-07These highlights do not include all the information needed to use MELOXICAM TABLETS safely and effectively. See full prescribing information for MELOXICAM TABLETS. MELOXICAM tablets, for oral use Initial U.S. Approval: 2000
50090-5339-12023-02-07These highlights do not include all the information needed to use MELOXICAM TABLETS safely and effectively. See full prescribing information for MELOXICAM TABLETS. MELOXICAM tablets, for oral use Initial U.S. Approval: 2000
50090-5339-22023-02-07These highlights do not include all the information needed to use MELOXICAM TABLETS safely and effectively. See full prescribing information for MELOXICAM TABLETS. MELOXICAM tablets, for oral use Initial U.S. Approval: 2000
50090-5339-32023-02-07These highlights do not include all the information needed to use MELOXICAM TABLETS safely and effectively. See full prescribing information for MELOXICAM TABLETS. MELOXICAM tablets, for oral use Initial U.S. Approval: 2000
50090-5339-42023-02-07These highlights do not include all the information needed to use MELOXICAM TABLETS safely and effectively. See full prescribing information for MELOXICAM TABLETS. MELOXICAM tablets, for oral use Initial U.S. Approval: 2000
50090-5339-62023-02-07These highlights do not include all the information needed to use MELOXICAM TABLETS safely and effectively. See full prescribing information for MELOXICAM TABLETS. MELOXICAM tablets, for oral use Initial U.S. Approval: 2000
50090-5339-72023-02-07These highlights do not include all the information needed to use MELOXICAM TABLETS safely and effectively. See full prescribing information for MELOXICAM TABLETS. MELOXICAM tablets, for oral use Initial U.S. Approval: 2000
50090-5339-02023-01-30These highlights do not include all the information needed to use MELOXICAM TABLETS safely and effectively. See full prescribing information for MELOXICAM TABLETS. MELOXICAM tablets, for oral use Initial U.S. Approval: 2000
50090-5339-12023-01-30These highlights do not include all the information needed to use MELOXICAM TABLETS safely and effectively. See full prescribing information for MELOXICAM TABLETS. MELOXICAM tablets, for oral use Initial U.S. Approval: 2000
50090-5339-22023-01-30These highlights do not include all the information needed to use MELOXICAM TABLETS safely and effectively. See full prescribing information for MELOXICAM TABLETS. MELOXICAM tablets, for oral use Initial U.S. Approval: 2000
50090-5339-32023-01-30These highlights do not include all the information needed to use MELOXICAM TABLETS safely and effectively. See full prescribing information for MELOXICAM TABLETS. MELOXICAM tablets, for oral use Initial U.S. Approval: 2000
50090-5339-42023-01-30These highlights do not include all the information needed to use MELOXICAM TABLETS safely and effectively. See full prescribing information for MELOXICAM TABLETS. MELOXICAM tablets, for oral use Initial U.S. Approval: 2000
50090-5339-62023-01-30These highlights do not include all the information needed to use MELOXICAM TABLETS safely and effectively. See full prescribing information for MELOXICAM TABLETS. MELOXICAM tablets, for oral use Initial U.S. Approval: 2000
50090-5339-72023-01-30These highlights do not include all the information needed to use MELOXICAM TABLETS safely and effectively. See full prescribing information for MELOXICAM TABLETS. MELOXICAM tablets, for oral use Initial U.S. Approval: 2000

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50090-5339-0meloxicam7 in 1 BOTTLETABLET78
50090-5339-1meloxicam14 in 1 BOTTLETABLET148
50090-5339-2meloxicam30 in 1 BOTTLETABLET308
50090-5339-3meloxicam60 in 1 BOTTLETABLET608
50090-5339-4meloxicam100 in 1 BOTTLETABLET1008
50090-5339-6meloxicam90 in 1 BOTTLETABLET908
50090-5339-7meloxicam10 in 1 BOTTLETABLET108

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50090-5339MELOXICAM TABLET [A-S MEDICATION SOLUTIONS]8Current NDC, Legacy NDC, 7 package rows20241215_7df126c1-a729-4bfe-9d08-ad359c9ee3bc.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50090-5339-0EA - Each50090-5339dcc0dcbc-9c09-4e03-9dad-203019c82e1312025-01-14
50090-5339-1EA - Each50090-53394d2f9bcd-814b-412a-9cc7-26ad850da6c312025-01-14
50090-5339-2EA - Each50090-53390fd779fc-9e79-491b-bed9-4b82b0d37b5712022-12-07
50090-5339-3EA - Each50090-53398bfafa48-ee26-4572-b009-31764dda6e9212025-01-14
50090-5339-4EA - Each50090-53391a8691b0-618c-47ce-ba84-789a2daba02812022-12-07
50090-5339-7EA - Each50090-5339e35ea426-fc32-4412-9ece-b16123819a8c12025-01-14

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 3 of 38 · 759 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MeloxicamMELOXICAMAdvanced Rx of Tennessee, LLC548ef3ed-ab67-ec85-e063-6294a90ab1da2026-07-20Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 152695
unii: VG2QF83CGL
PridICHTHAMMOL, CALCIUM SULFIDE, CALENDULA OFFICINALIS FLOWERING TOP, ARNICA MONTANA, ECHINACEA ANGUSTIFOLIA, SILICON DIOXIDE, SULFURHyland's Inc.49689eeb-7790-07f1-e063-6294a90a2df22026-07-16WarningsExact identifier
unii: ETJ7Z6XBU4
QAMZOVAMELOXICAMNanjing Delova Biotech Co., Ltd.385fd779-1be1-49ae-8213-750b96ecc9972026-07-16Boxed warning, Warnings, Adverse reactionsExact identifier
unii: VG2QF83CGL
Leg Cramps PMOYSTER SHELL CALCIUM CARBONATE, CRUDE, CAUSTICUM, MATRICARIA RECUTITA, CINCHONA OFFICINALIS BARK, COPPER, LYCOPODIUM CLAVATUM SPORE, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, TOXICODENDRON PUBESCENS LEAF, SILICON DIOXIDE, AND SULFURHyland's Inc.b0574a7e-88fa-417e-b6d5-60ced59eba472026-07-15WarningsExact identifier
unii: ETJ7Z6XBU4
meloxicamMELOXICAMCoupler LLC56440abd-80f4-7b8d-e063-6394a90a2a912026-07-10Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 311486
unii: VG2QF83CGL
Jacksons Cell Salts SILICA 12X 12SILICEAZettl Health Inc.5647dafc-1fff-6a25-e063-6294a90a8b4f2026-07-10Exact identifier
unii: ETJ7Z6XBU4
The Cell Salt Co. Daily Blend 12 in 1CALC FLUOR, CALC PHOS, CALC SULPH, FERRUM PHOS, KALI MUR, KALI PHOS, KALI SULPH, MAG PHOS, NAT MUR, NAT PHOS, NAT SULPH, SILICEAThe Cell Salt Company LLC55826f59-acf4-7370-e063-6394a90afed72026-07-01WarningsExact identifier
unii: ETJ7Z6XBU4
Bambusa StannumBAMBUSA STANNUMUriel Pharmacy Inc.a0d4d0ac-e2d2-4381-8f93-e417195218592026-06-30WarningsExact identifier
unii: ETJ7Z6XBU4
meloxicamMELOXICAMHAWAII REPACK, INC.68b50c82-7130-428a-884c-98576887e99a2026-06-26Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 311486
rxcui: 152695
unii: VG2QF83CGL
MeloxicamMELOXICAMTerrain Pharmaceuticals, Inc.b603255e-1fcf-42ec-ab62-9aa321cb7ac62026-06-25Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 311486
rxcui: 152695
unii: VG2QF83CGL
meloxicamMELOXICAMREMEDYREPACK INC.5d153147-f1c8-4624-8028-fe84680d71432026-06-25Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 152695
unii: VG2QF83CGL
meloxicamMELOXICAMREMEDYREPACK INC.3e8a6283-1e1b-4199-ac73-f42255c7e9072026-06-22Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 311486
unii: VG2QF83CGL
meloxicamMELOXICAMREMEDYREPACK INC.ffaf1db4-25a9-48d1-a624-242f9d8e14c72026-06-22Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 311486
unii: VG2QF83CGL
meloxicamMELOXICAMSt. Mary's Medical Park Pharmacyb710b959-a64d-a631-e053-2995a90a21772026-06-20Boxed warning, Warnings, Adverse reactionsExact identifier
application number: ANDA077921
rxcui: 311486
unii: VG2QF83CGL
H-Scars FormulaCALENDULA OFFICINALLIS, SILICEAHealing Natural Oils LLC8433ff00-d815-45e0-b0ec-1448668dd8f82026-06-16WarningsExact identifier
unii: ETJ7Z6XBU4
meloxicamMELOXICAMPreferred Pharmaceuticals, Inc.66bc3f93-a73b-476c-83d4-7354d2e185752026-06-15Boxed warning, Warnings, Adverse reactionsExact identifier
application number: ANDA077921
rxcui: 311486
unii: VG2QF83CGL
E-Z-GAS IIANTACID/ANTIFLATULENTE-Z-EM, INC.4e12e1cb-b033-076d-e054-00144ff8d46c2026-06-15WarningsExact identifier
unii: ETJ7Z6XBU4
ACD ACITRIC ACID MONOHYDRATE, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATETerumo BCT, Ltd.395aec48-198a-4aed-8e38-7accfb3232f92026-06-15Warnings, Adverse reactionsExact identifier
unii: B22547B95K
BM BIO28 ALCOHOLCALC SULPH, CALC FLUOR, CALC PHOS, FERR PHOS, KALI MUR, KALI PHOS, KALI SULPH, MAG PHOS, NAT PHOS, NAT SULPH, NAT MUR, SILICEATotal Operations Management LLC DBA:Bestmade Natural Products Micro544b66c4-49df-556f-e063-6394a90af3ed2026-06-15WarningsExact identifier
unii: ETJ7Z6XBU4
meloxicamMELOXICAMPreferred Pharmaceuticals Inc.e0deb1f7-b575-463f-a3f8-304cc19360752026-06-15Boxed warning, Warnings, Adverse reactionsExact identifier
application number: ANDA077921
rxcui: 152695
unii: VG2QF83CGL

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.